268 related articles for article (PubMed ID: 9712097)
21. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
Higgins GC; Wu Y; Postlethwaite AE
J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
[TBL] [Abstract][Full Text] [Related]
22. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
Distler JH; Jüngel A; Caretto D; Schulze-Horsel U; Kowal-Bielecka O; Gay RE; Michel BA; Müller-Ladner U; Kalden JR; Gay S; Distler O
Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517
[TBL] [Abstract][Full Text] [Related]
23. Diminished interleukin-8 (IL-8) production in the fetal wound healing response.
Liechty KW; Crombleholme TM; Cass DL; Martin B; Adzick NS
J Surg Res; 1998 Jun; 77(1):80-4. PubMed ID: 9698538
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
25. IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes.
Wang X; Bi Z; Chu W; Wan Y
Int J Mol Med; 2005 Dec; 16(6):1117-24. PubMed ID: 16273295
[TBL] [Abstract][Full Text] [Related]
26. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.
Fukasawa C; Kawaguchi Y; Harigai M; Sugiura T; Takagi K; Kawamoto M; Hara M; Kamatani N
Eur J Immunol; 2003 Oct; 33(10):2792-800. PubMed ID: 14515263
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor (PDGF) activates primitive hematopoietic precursors (pre-CFCmulti) by up-regulating IL-1 in PDGF receptor-expressing macrophages.
Yan XQ; Brady G; Iscove NN
J Immunol; 1993 Mar; 150(6):2440-8. PubMed ID: 8450221
[TBL] [Abstract][Full Text] [Related]
28. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
Zhou X; Tan FK; Stivers DN; Arnett FC
Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha.
Sasaki M; Kashima M; Ito T; Watanabe A; Izumiyama N; Sano M; Kagaya M; Shioya T; Miura M
Mediators Inflamm; 2000; 9(3-4):155-60. PubMed ID: 11132772
[TBL] [Abstract][Full Text] [Related]
30. Regulation of platelet-derived growth factor receptor expression by cell context overrides regulation by cytokines.
Barrett TB; Seifert RA; Bowen-Pope DF
J Cell Physiol; 1996 Oct; 169(1):126-38. PubMed ID: 8841429
[TBL] [Abstract][Full Text] [Related]
31. The immunobiology of systemic sclerosis.
Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression.
Battegay EJ; Raines EW; Colbert T; Ross R
J Immunol; 1995 Jun; 154(11):6040-7. PubMed ID: 7751646
[TBL] [Abstract][Full Text] [Related]
33. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
Liu T; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
35. Platelet-derived growth factor-induced arachidonic acid release for enhancement of prostaglandin E(2) synthesis in human gingival fibroblasts pretreated with interleukin-1beta.
Nakao S; Ogata Y; Yamamoto Y; Furuyama S; Sugiya H
J Cell Biochem; 2004 Jun; 92(3):579-90. PubMed ID: 15156569
[TBL] [Abstract][Full Text] [Related]
36. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
[TBL] [Abstract][Full Text] [Related]
37. Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.
Kawaguchi Y; Hara M; Wright TM
J Clin Invest; 1999 May; 103(9):1253-60. PubMed ID: 10225968
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1.
Giacomelli R; Cipriani P; Danese C; Pizzuto F; Lattanzio R; Parzanese I; Passacantando A; Perego MA; Tonietti G
J Rheumatol; 1996 Feb; 23(2):291-6. PubMed ID: 8882034
[TBL] [Abstract][Full Text] [Related]
39. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
[TBL] [Abstract][Full Text] [Related]
40. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
